Details for 2019205426
Up to date per 03.04.2026
Actions
Details for 2019205426
Granted/Registered
European Patent
03.06.2020 A
09.06.2021 B1
15.11.2012
US
201261727094 P
C07K 7/00 20060101AFI20210111BHEP
Owner
Apellis Pharmaceuticals, Inc.100 5th Avenue Waltham, MA 02451US
Representative
Representative
Patentanwaltskanzlei Matschnig & Forsthuber OGBiberstraße 221010 WienAT
Inventor
FRANCOIS, Cedric1726 Riverside Drive Prospect, KY 40059US
DESCHATELETS, Pascal9506 Delphinium St. Prospect, KY 40059US
Information about Fees